Holding(s) in Company

5th Feb 2007 15:04

Allergy Therapeutics PLC05 February 2007 Allergy Therapeutics plc Holding in Company Allergy Therapeutics plc (the "Company") received notification on 31 January2007 from AXA Investment Managers UK Ltd that, following a purchase of 6,029,620ordinary shares of 0.1 pence each ("Ordinary Shares"), AXA S.A. and its groupcompanies are interested in 6,029,620 Ordinary Shares, comprising a beneficialinterest of 2,500,000 Ordinary Shares and a non-beneficial interest of 3,529,620Ordinary Shares, representing 7.36 per cent. of the Company's issued sharecapital of 81,950,632 Ordinary Shares, as detailed below: Company / Fund Holding % AXA Framlington Xerox Final Salary Pension Scheme 447,250 0.55(Non-beneficial)AXA Framlington Islington Group Pension Scheme 280,832 0.34(Non-beneficial)AXA Framlington SEI UK Equity 450,000 0.55(Non-beneficial)AXA Framlington Throgmorton Trust 2,500,000 3.05(Beneficial)AXA Framlington UK Smaller Companies 1,600,000 1.95(Non-beneficial)AXA Framlington Biotech 283,200 0.35(Non-beneficial)AXA Framlington BAE Systems Pensions Fund CIF Trustees 325,644 0.40(Non-beneficial)AXA Framlington BAE Systems 2000 Pensions Fund 142,694 0.17(Non-beneficial) Total 6,029,620 7.36% This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

Allergy Thera.